Prognostic value of glomerular function estimated by Cockcroft-Gault creatinine clearance, MDRD-4, CKD-EPI and European Kidney Function Consortium equations in patients with acute coronary syndromes.


Journal

Clinica chimica acta; international journal of clinical chemistry
ISSN: 1873-3492
Titre abrégé: Clin Chim Acta
Pays: Netherlands
ID NLM: 1302422

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 21 07 2021
revised: 25 08 2021
accepted: 10 09 2021
pubmed: 17 9 2021
medline: 15 12 2021
entrez: 16 9 2021
Statut: ppublish

Résumé

It remains unknown which equation used to assess the glomerular function is better for risk stratification in patients with acute coronary syndrome (ACS). This study included 3985 patients with ACS. Glomerular function was assessed using 4 equations: the Cockcroft-Gault creatinine clearance (C-G For each 30 ml/min decrement, the adjusted hazard ratio [HR] with 95% confidence interval [CI] for one-year mortality was 1.67 [1.27-2.25] for C-G In patients with ACS, C-G NCT01944800.

Sections du résumé

BACKGROUND BACKGROUND
It remains unknown which equation used to assess the glomerular function is better for risk stratification in patients with acute coronary syndrome (ACS).
METHODS METHODS
This study included 3985 patients with ACS. Glomerular function was assessed using 4 equations: the Cockcroft-Gault creatinine clearance (C-G
RESULTS RESULTS
For each 30 ml/min decrement, the adjusted hazard ratio [HR] with 95% confidence interval [CI] for one-year mortality was 1.67 [1.27-2.25] for C-G
CONCLUSIONS CONCLUSIONS
In patients with ACS, C-G
CLINICAL TRIAL REGISTRATION BACKGROUND
NCT01944800.

Identifiants

pubmed: 34529983
pii: S0009-8981(21)00318-1
doi: 10.1016/j.cca.2021.09.007
pii:
doi:

Substances chimiques

Creatinine AYI8EX34EU

Banques de données

ClinicalTrials.gov
['NCT01944800']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-113

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Gjin Ndrepepa (G)

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany. Electronic address: ndrepepa@dhm.mhn.de.

Stefan Holdenrieder (S)

Institut für Laboratoriumsmedizin, Deutsches Herzzentrum München, Technische Universität, Munich, Germany.

Franz-Josef Neumann (FJ)

Department of Cardiology and Angiology II, University Heart Center Freiburg Bad Krozingen, Bad Krozingen, Germany.

Shqipdona Lahu (S)

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

Salvatore Cassese (S)

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

Michael Joner (M)

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Germany.

Erion Xhepa (E)

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

Sebastian Kufner (S)

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

Jens Wiebe (J)

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

Karl-Ludwig Laugwitz (KL)

German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Germany; Medizinische Klinik und Poliklinik Innere Medizin I (Kardiologie, Angiologie, Pneumologie), Klinikum rechts der Isar, Munich, Germany.

Senta Gewalt (S)

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

Heribert Schunkert (H)

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Germany.

Adnan Kastrati (A)

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH